Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients (2010)
- Authors:
- USP affiliated authors: KATAYAMA, MARIA LUCIA HIRATA - FM ; BRENTANI, MARIA MITZI - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM
- Unidade: FM
- DOI: 10.1590/s0100-879x2010007500135
- Subjects: BIOMARCADORES; MARCADOR MOLECULAR; NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA); QUIMIOTERAPIA ADJUVANTE; GENES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Medical and Biological Research
- ISSN: 0100-879X
- Volume/Número/Paginação/Ano: n. 43, n. 12, p. 1225-1231, 2010
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BARROS FILHO, M. C et al. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Brazilian Journal of Medical and Biological Research, n. 12, p. 1225-1231, 2010Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2010007500135. Acesso em: 01 out. 2024. -
APA
Barros Filho, M. C., Katayama, M. L. H., Brentani, H., Abreu, A. P. S., Barbosa, E. M., Oliveira, C. T., et al. (2010). Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Brazilian Journal of Medical and Biological Research, ( 12), 1225-1231. doi:10.1590/s0100-879x2010007500135 -
NLM
Barros Filho MC, Katayama MLH, Brentani H, Abreu APS, Barbosa EM, Oliveira CT, Góes JCS, Brentani MM, Folgueira MAAK. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2010 ;( 12): 1225-1231.[citado 2024 out. 01 ] Available from: https://doi.org/10.1590/s0100-879x2010007500135 -
Vancouver
Barros Filho MC, Katayama MLH, Brentani H, Abreu APS, Barbosa EM, Oliveira CT, Góes JCS, Brentani MM, Folgueira MAAK. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2010 ;( 12): 1225-1231.[citado 2024 out. 01 ] Available from: https://doi.org/10.1590/s0100-879x2010007500135 - HC11 mouse mammary cells are growth inhibited by EB1089 and K1060 with a late induction of TGF-beta expression whether HC11 HA-RAS transfomed cells proliferation is not affected by these compounds
- Transcriptional profile and response to neoadjuvant chemotherapy in breast cancer
- Expression of the mRNA of the vitamid D receptor in hippocampal formation of rats submitted to temporal lobe epilepsy induced by pilocarpine
- Gene expression profiling of clinical stages II and III breast cancer
- Molecular characterization of carcinoma-associated fibroblasts and those derived from normal breast tissue
- Genes modulados em fibroblastos de linfonodos comprometidos ou não comprometidos de pacientes com câncer de mama por influência de fatores solúveis liberados por células epiteliais mamárias normais (MCF10A) ou malignas (MDA-MB231) em um modelo de co-cultura
- Normal HC11 and ras-transformed mouse mammary cells are resistant to the antiproliferative effects of retinoic acid
- Perfil de expressão gênica de fibroblastos obtidos de tecido mamário normal, peritumoral e tumoral de câncer de mama
- Influence of malignant breast cancer cell on the gene expression of fibroblasts obtained from involved [FN(+)]or uninvolved [FN(-)] lymph nodes of breast cancer patient
- Human breast tumor slices: A model for identification of vitamin D regulated genes in the tumor microenvironment
Informações sobre o DOI: 10.1590/s0100-879x2010007500135 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
